Targeted therapies for resectable lung adenocarcinoma: ADAURA opens for thoracic oncologic surgeons Editorial


Authors: Jones, D. R.; Wu, Y. L.; Tsuboi, M.; Herbst, R. S.
Title: Targeted therapies for resectable lung adenocarcinoma: ADAURA opens for thoracic oncologic surgeons
Keywords: cancer chemotherapy; cancer survival; cancer surgery; overall survival; gene deletion; cancer recurrence; cisplatin; erlotinib; drug safety; treatment duration; drug approval; disease free survival; cancer staging; medical decision making; metastasis; epidermal growth factor receptor; editorial; cancer research; lung adenocarcinoma; adjuvant chemotherapy; surgeon; gefitinib; clinical effectiveness; neoadjuvant chemotherapy; egfr; point mutation; lung surgery; genetic screening; lobectomy; randomized controlled trial (topic); clinical trial (topic); molecularly targeted therapy; human; osimertinib; vinorelbine tartrate; adaura
Journal Title: Journal of Thoracic and Cardiovascular Surgery
Volume: 162
Issue: 1
ISSN: 0022-5223
Publisher: Mosby Elsevier  
Date Published: 2021-07-01
Start Page: 288
End Page: 292
Language: English
DOI: 10.1016/j.jtcvs.2021.02.008
PUBMED: 33691940
PROVIDER: scopus
PMCID: PMC8519337
DOI/URL:
Notes: Editorial -- Export Date: 1 July 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Randolph Jones
    417 Jones